Modi-Mundipharma Private Limited, a active private limited company, was established on 31 October 1990 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U74899DL1990PTC041928. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹3.00 M.
Formerly known as Modi-Mundipharma Limited. It upholds a compliant status. Its leadership includes Abhishek Modi (Director), Kumkum Modi (Director), Umesh Kumar Modi (Director). Past directors included Arun Kapoor, Kaare Madsen, Jagan Nath Khurana. It holds ₹251.75 Cr open charges and ₹198.98 Cr settled loans. Its latest AGM occurred on 31 December 2024, with the balance sheet filed on 31 March 2024. It is based at 1400 Modi Tower98 Nehru Place, New Delhi, Delhi, 110019.
U74899DL1990PTC041928
041928
31 October 1990
₹1.00 Cr
₹3.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Modi-Mundipharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhishek Modi | Director | 15 Feb 1995 | Current |
| Kumkum Modi | Director | 28 Apr 1993 | Current |
| Umesh Kumar Modi | Director | 31 Oct 1990 | Current |
| Meghna Modi | Director | 25 Mar 1991 | Current |
| Jayesh Modi | Director | 13 Sep 2012 | Current |
| Bryan George Lea | Director | 04 Jun 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Alternate Director | 15 Nov 2006 | Past |
| Pramod Abcsdd | Director | 15 Aug 2011 | Past |
| Pramod Abcsdd | Alternate Director | 29 Dec 2020 | Past |
| Pramod Abcsdd | Alternate Director | 14 May 2019 | Past |
| Pramod Abcsdd | Director | 24 Mar 2010 | Past |
| Pramod Abcsdd | Alternate Director | 20 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Modi-Mundipharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.86% decrease. The company also saw a substantial fall in profitability, with a 83% decrease in profit. The company's net worth moved up by a moderate rise of 6.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Modi-Mundipharma had a promoter holding of 100.00%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,517,500,000.00
₹1,989,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Feb 2021 | Hdfc Bank Limited | ₹10.00 Cr | Open |
| 12 Jul 2017 | Hdfc Bank Limited | ₹2.10 Cr | Open |
| 12 Jul 2017 | Hdfc Bank Limited | ₹16.64 Cr | Open |
| 10 Feb 2014 | Others | ₹223.01 Cr | Open |
| 14 Apr 2022 | Others | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Modi-Mundipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Modi-Mundipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Modi-Mundipharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vijay Kumar Modi was appointed as a Additional Director was appointed as a Additional Director on 12 Aug 2025 & has been associated with this company since 5 months 5 days . was documented.
The activity Modi-Mundipharma Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records. was completed.
Progress on Modi-Mundipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on A charge with Others of Rs. 223.01 Cr registered on 10 Feb 2014 with Charge ID 10481271 was modified on 27 Feb 2024. was documented.
Progress on Sonam Chuni was appointed as a Company Secretary was appointed as a Company Secretary on 12 Jul 2023 & has been associated with this company since 2 years 6 months . was documented.
The activity A charge registered on 14 Apr 2022 via Charge ID 100566726 with Others was fully satisfied on 01 Nov 2022. was completed.
The CIN of Modi-Mundipharma Private Limited is U74899DL1990PTC041928.
Modi-Mundipharma Private Limited is headquartered at 1400 Modi Tower98 Nehru Place, New Delhi, Delhi, 110019.
Modi-Mundipharma Private Limited was incorporated on 31 October 1990.
The current directors of Modi-Mundipharma Private Limited are
The primary industry of Modi-Mundipharma Private Limited is Manufacturing.
Modi-Mundipharma Private Limited is unlisted.
The authorized capital of Modi-Mundipharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹3.00 M.
The compliance status of Modi-Mundipharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX